Glassman Wealth Services’s GenMark Diagnostics, Inc GNMK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-116
Closed -$3K 1753
2021
Q1
$3K Hold
116
﹤0.01% 1049
2020
Q4
$2K Buy
+116
New +$1.54K ﹤0.01% 1138

Glassman Wealth Services's GNMK Position: Q2 2021 in Review

Glassman Wealth Services sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 116 shares — an estimated $3K sold.

Glassman Wealth Services first reported a position in GNMK in Q4 2020 and held it in 2 quarters. The position peaked at $3K in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

  • Glassman Wealth Services reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
  • Glassman Wealth Services sold 116 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $3K.
  • Glassman Wealth Services first reported a position in GenMark Diagnostics, Inc in Q4 2020 and held it in 2 quarters.
  • Glassman Wealth Services's GenMark Diagnostics, Inc position peaked at $3K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Glassman Wealth Services's 13F filing for Q2 2021, filed 4 Aug 2021.